These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35503651)

  • 1. The impact of nebulized epoprostenol and iloprost on hemoglobin oxygen affinity: an ex vivo experiment.
    Woyke S; Mair N; Haller T; Ronzani M; Plunser D; Oberacher H; Gatterer H; Rugg C; Ströhle M
    Am J Physiol Lung Cell Mol Physiol; 2022 Jun; 322(6):L898-L903. PubMed ID: 35503651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose- and Sex-Dependent Changes in Hemoglobin Oxygen Affinity by the Micronutrient 5-Hydroxymethylfurfural and α-Ketoglutaric Acid.
    Woyke S; Mair N; Ortner A; Haller T; Ronzani M; Rugg C; Ströhle M; Wintersteiger R; Gatterer H
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
    Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
    Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex dependent effects of cardiovascular agents on hemoglobin oxygen affinity - An ex-vivo experiment.
    Woyke S; Ronzani M; Mair N; Frisch C; Marcher K; Haller T; Ströhle M; Rugg C
    J Crit Care; 2024 Sep; 85():154916. PubMed ID: 39299023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broad diversity in oxygen affinity to haemoglobin.
    Balcerek B; Steinach M; Lichti J; Maggioni MA; Becker PN; Labes R; Gunga HC; Persson PB; Fähling M
    Sci Rep; 2020 Oct; 10(1):16920. PubMed ID: 33037242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes.
    Sprague RS; Bowles EA; Hanson MS; DuFaux EA; Sridharan M; Adderley S; Ellsworth ML; Stephenson AH
    Microcirculation; 2008 Jul; 15(5):461-71. PubMed ID: 18574748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of desflurane, isoflurane and sevoflurane on the hemoglobin oxygen dissociation curve in human blood samples.
    Ronzani M; Woyke S; Mair N; Gatterer H; Oberacher H; Plunser D; Haller T; Ströhle M; Rugg C
    Sci Rep; 2022 Aug; 12(1):13633. PubMed ID: 35948604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo.
    Kisch-Wedel H; Kemming G; Meisner F; Flondor M; Bruhn S; Koehler C; Messmer K; Zwissler B
    Eur J Pharmacol; 2005 Jul; 517(3):208-16. PubMed ID: 15993879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
    Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
    Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GBT1118, a potent allosteric modifier of hemoglobin O
    Dufu K; Yalcin O; Ao-Ieong ESY; Hutchaleelala A; Xu Q; Li Z; Vlahakis N; Oksenberg D; Lehrer-Graiwer J; Cabrales P
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H381-H391. PubMed ID: 28526710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hemoglobin affinity for oxygen with GBT1118 improves hypoxia tolerance in sickle cell mice.
    Dufu K; Williams AT; Muller CR; Walser CM; Lucas A; Eaker AM; Alt C; Cathers BE; Oksenberg D; Cabrales P
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H400-H411. PubMed ID: 34213392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary response to large decreases of hemoglobin-O2 affinity in isolated rat heart.
    Stücker O; Vicaut E; Villereal MC; Ropars C; Teisseire BP; Duvelleroy MA
    Am J Physiol; 1985 Dec; 249(6 Pt 2):H1224-7. PubMed ID: 4073286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite effects of prostacyclin on hepatic blood flow and oxygen consumption after burn and sepsis.
    Tadros T; Traber DL; Herndon DN
    Ann Surg; 2004 Jan; 239(1):67-74. PubMed ID: 14685102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig.
    Corriu C; Félétou M; Edwards G; Weston AH; Vanhoutte PM
    Eur J Pharmacol; 2001 Aug; 426(1-2):89-94. PubMed ID: 11525776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of modifying O2 diffusivity and delivery on glomerular and tubular function in hypoxic perfused kidney.
    Baines AD; Adamson G; Wojciechowski P; Pliura D; Ho P; Kluger R
    Am J Physiol; 1998 Apr; 274(4):F744-52. PubMed ID: 9575899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity.
    Sakai H; Tsai AG; Rohlfs RJ; Hara H; Takeoka S; Tsuchida E; Intaglietta M
    Am J Physiol; 1999 Feb; 276(2):H553-62. PubMed ID: 9950857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell oxygen transport in man in relation to gender and age.
    Humpeler E; Vogel S; Schobersberger W; Mairbäurl H
    Mech Ageing Dev; 1989 Mar; 47(3):229-39. PubMed ID: 2716369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.